| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.009 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |